Titan Biotech Limited

BSE:524717 Stock Report

Market Cap: ₹6.2b

Titan Biotech Past Earnings Performance

Past criteria checks 5/6

Titan Biotech has been growing earnings at an average annual rate of 11.8%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 12.4% per year. Titan Biotech's return on equity is 17.4%, and it has net margins of 15%.

Key information

11.8%

Earnings growth rate

11.9%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate12.4%
Return on equity17.4%
Net Margin15.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Titan Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524717 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,6892532870
30 Jun 241,7242512460
31 Mar 241,6412492680
31 Dec 231,6102482500
30 Sep 231,4532092360
30 Jun 231,4032272230
31 Mar 231,4402482100
31 Dec 221,4032491800
30 Sep 221,4642681740
30 Jun 221,5002491730
31 Mar 221,2352171490
31 Dec 211,5382411650
30 Sep 211,5252551610
30 Jun 211,4432631480
31 Mar 211,4223031460
31 Dec 201,2682851520
30 Sep 201,1092361480
30 Jun 209681781260
31 Mar 20794711430
31 Dec 19766581350
30 Sep 19728491250
30 Jun 19713461080
31 Mar 19649351170
31 Dec 1865946610
30 Sep 1866241580
30 Jun 1862734360
31 Mar 1857425860
31 Dec 1758727730
30 Sep 1755722670
30 Jun 1753523500
31 Mar 1752722390
31 Dec 1650318480
30 Sep 1649420460
30 Jun 1648418370
31 Mar 1645818420
31 Dec 1545116650
30 Sep 1541916640
30 Jun 1540816280
31 Mar 1540316320
31 Dec 1439516600
30 Sep 1440516590
30 Jun 1441515240
31 Mar 1439115560
31 Dec 1335515450

Quality Earnings: 524717 has high quality earnings.

Growing Profit Margin: 524717's current net profit margins (15%) are higher than last year (14.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524717's earnings have grown by 11.8% per year over the past 5 years.

Accelerating Growth: 524717's earnings growth over the past year (20.9%) exceeds its 5-year average (11.8% per year).

Earnings vs Industry: 524717 earnings growth over the past year (20.9%) exceeded the Chemicals industry 8%.

Return on Equity

High ROE: 524717's Return on Equity (17.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 12:21
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Titan Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution